Hepatobiliary Tumor Department

The Department of Hepatobiliary Oncology of Tianjin Medical University Cancer Hospital was formerly known as the Department of Abdominal Oncology Surgery of Tianjin Medical University Cancer Hospital. It gradually developed and expanded with the efforts of a large number of famous experts such as Wang Dianchang, Hao Xishan, and Li Qiang, and trained and trained a large number of influential experts in abdominal oncology surgery at home and abroad.

In 1998, it became an independent department of hepatobiliary oncology. In recent years, relying on the overall multidisciplinary advantages of Tianjin Medical University Cancer Hospital, it has achieved rapid development and has become an internationally advanced and domestically leading position.

Approved as a doctorate-granting site in 1999, it is the leading unit of hepatobiliary tumor surgery in Tianjin that integrates medical care, teaching, and scientific research.

Department status

In addition to the general outpatient clinic, specialist outpatient clinic and special outpatient clinic for hepatobiliary tumors, this department also has a combined hepatobiliary tumor clinic (MDT), including the Department of Hepatobiliary Oncology, Department of Gastrointestinal Oncology, Department of Radiotherapy, Department of Interventional Therapy, Department of Biotherapy, Department of Ultrasound, Department of Radiology, and Department of Pathology. A total of 8 experts visit at the same time to jointly formulate treatment plans for patients.

The annual outpatient volume of the department can reach 20,000, among which the joint hepatobiliary tumor clinic completes more than 200 difficult case consultations every year.

It currently has 2 floors of general wards and 1 intensive care unit, with a total of 118 beds.

It treats more than 3,500 patients every year, and the hospital bed utilization rate reaches 110%.

Most of the patients admitted are difficult cases referred from various medical units in the city and North and Northeast China. The number of surgeries throughout the year reached more than 2,000.

The department ward has instruments and equipment that are in line with international standards such as color ultrasound Doppler diagnostic instrument, liver reserve function tester, three-dimensional liver reconstruction and liver volume assessment instrument, ultrasonic surgical aspirator (CUSA), STORZ laparoscope, radiofrequency ablation instrument, etc., which has greatly enhanced the sustainable development capabilities of medical technology and has always been at the international advanced and domestic leading level.

Medical professional features

Surgical treatment of liver cancer:

Anatomic liver resection and precision liver resection;

Anterior approach liver resection;

Very large liver resection;

Glisson sheath transverse liver resection;

Liver segment staining hepatectomy;

Ex vivo liver resection;

Bloodless hepatectomy with total hepatic blood flow obstruction;

Preoperative portal vein embolization and second-stage liver resection;

Re-resection of recurrent liver cancer;

Laparoscopic hemihepatectomy and segmental liver resection;

Combined liver dissection and portal vein ligation two-step hepatectomy (ALPPS).

Radiofrequency ablation treatment of liver tumors:

Percutaneous radiofrequency ablation of liver tumors (including artificial chest and radiofrequency ablation of liver tumors under ascites);

Laparoscopic radiofrequency ablation of liver tumors;

Open radiofrequency ablation of liver tumors;

Radical resection of gallbladder cancer according to T stage.

Radical resection of hilar cholangiocarcinoma:

Radical resection of hilar cholangiocarcinoma combined with hemihepatectomy and caudate lobe resection;

Radical revascularization for hilar cholangiocarcinoma.

Pancreatoduodenectomy:

Various laparoscopic pancreaticoduodenectomies for distal cholangiocarcinoma, pancreatic cancer, and ampullary cancer;

duodenum-preserving pancreatic head resection;

Pancreatic head-preserving duodenectomy;

Hemihepatectomy combined with pancreaticoduodenectomy;

Revascularized pancreaticoduodenectomy.

Robotic hepatobiliary and pancreatic surgery

The department pays attention to the promotion of medical technology and hosts a number of seminars and classes on clinical diagnosis and treatment of hepatobiliary tumors every year, achieving good profits and reputation.

The Tianjin Hepatobiliary Surgery Young Physician Salon is held regularly to update new treatment concepts, new methods, and new technologies in a timely manner.

The International Summit Forum on Standardized Diagnosis and Treatment of Hepatobiliary Tumors is held every two years, and famous domestic and foreign hepatobiliary surgery experts are invited to attend and give lectures.

Concept technology frontier

EARS

Enhanced recovery after surgery (ERAS): refers to a series of optimization measures for perioperative treatment using evidence-based medical evidence to reduce the physical and psychological traumatic stress of surgical patients and achieve rapid recovery.

Professor Song Tianqiang, director of the department, applied the concept of rapid postoperative recovery to the clinical practice of surgery in our hospital and achieved good results. In 2006, he received a scientific research fund project supported by the Tianjin Municipal Health and Family Planning Commission.

It has now become a routine diagnosis and treatment measure in the department, shortening hospitalization time, reducing postoperative complications, and reducing patients' financial burden.

MDT

Multidisciplinary collaborative treatment model (multiple disciplinary team, MDT): refers to a clinical multidisciplinary team, that is, a clinical discussion meeting held by multidisciplinary experts around a certain case, and a treatment plan is formulated for the patient based on the comprehensive opinions of various disciplines.

Because of its distinctive patient-centered and individualized treatment characteristics.

MDT has become an important mode of disease treatment in large foreign hospitals and tumor treatment centers.

In October 2011, Tianjin Medical University Cancer Hospital established a domestic joint outpatient clinic focusing on the treatment of difficult hepatobiliary tumors (hepatobiliary tumor multidisciplinary comprehensive diagnosis and treatment joint outpatient clinic), and has many joint disciplines (hepatobiliary tumor surgery, digestive oncology, internal medicine, Department of Interventional Therapy, Department of Radiation Therapy, Department of Biotherapy, Department of Ultrasound Diagnosis and Treatment, Department of Radiology, Department of Pathology), each year treats about 200 difficult cases of hepatobiliary tumors from all over the country, which has improved the comprehensive diagnosis and treatment level and efficacy of difficult cases of hepatobiliary tumors in our hospital.

Radiofrequency ablation treatment of liver tumors based on liver surgery technology support

Radiofrequency ablation is an emerging technology in recent years. For some small liver tumors, it can achieve effects close to surgical treatment. This technology is mostly mastered by doctors in the ultrasound department and oncology department. The indications for surgery are not well understood, which blindly expands the indications for radiofrequency ablation treatment.

Based on the support of liver surgery technology, our department strictly distinguishes the indications of surgery and radiofrequency ablation, and chooses surgery or radiofrequency ablation based on the patient's individual condition in order to achieve the best results.

Radical resection of gallbladder cancer based on TNM staging and T staging of gallbladder cancer

Gallbladder cancer is discovered late and has a poor prognosis. It is often discovered accidentally during diagnosis and treatment in general hospitals or during surgery. General hospitals have certain deviations in the radical treatment of gallbladder cancer.

Our department implements different surgical treatment plans based on the TNM stage and T stage of gallbladder cancer.

Simple cholecystectomy is performed for T1a gallbladder cancer.

For T1b gallbladder cancer, combined resection of liver segments IVb and V and hepatoduodenal ligament lymph node dissection are required.

Talent training and medical education

The Department of Hepatobiliary Oncology has strong technical force, focuses on talent training, and has a reasonable talent echelon composed of old, middle-aged and young people.

We have a professional, young, high-level academic team with teamwork spirit.

There are currently 66 medical staff, including 1 academician of the Chinese Academy of Engineering, 2 experts enjoying national special subsidies, 1 new century outstanding talent from the Ministry of Education, 3 Tianjin “131 Innovative” talents, 2 professors and doctoral supervisors, 2 master supervisors, 5 chief physicians, 4 deputy chief physicians, 4 attending physicians, and 3 resident physicians.

The Department of Hepatobiliary Oncology has always attached great importance to talent training and introduction. All doctors have obtained doctorate degrees, including one doctor in Japan, 10 of whom have returned from studying abroad, and studied in Japan and Australia respectively. Many doctors are studying in internationally renowned hepatobiliary surgery centers.

There are 6 nurses with master's degrees.

The number, age structure, and academic structure of medical staff are reasonable.

The department is responsible for clinical teaching, internship and internship teaching for foreign students in the seven-year program of Tianjin Medical University and the International College, and is responsible for doctoral and master's degree education in hepatobiliary oncology.

It recruits doctoral and master's degree students from all over the country, and also recruits foreign master's degree students.

Every year, we accept clinical training doctors from all over the country to promote new medical technologies.

All doctors in the department can undertake the teaching tasks of basic clinical courses and internship teaching tasks for medical students of the Medical University. At the same time, some teachers also undertake the English teaching of the International School of Clinical Medicine.

The characteristics of postgraduate training in this discipline are the close integration of theory and practice, and equal emphasis on scientific research and clinical skills, making them comprehensive talents with strong clinical work ability, teaching ability and scientific research ability.

Academic exchange

The department pays attention to mutual exchanges and learning at home and abroad, and has sent doctors to visit and study at home and abroad many times. It has also maintained good long-term academic exchanges and cooperation with the University of Tokyo Hospital in Japan, Towa Hospital in Japan, Bundang Hospital of the National University of Korea, Kaohsiung Chang Gung Memorial Hospital in Taiwan, National Taiwan University Hospital, Yadong Memorial Hospital in Taiwan, and Changbin Hideden Hospital in Taiwan. Relevant experts have been invited to give lectures and exchanges many times.

Many doctors have long-term study and training experience abroad, which has established a stable international communication channel for the department.

Many experts from the department have given special academic reports at international academic conferences and won high praise from foreign colleagues.

The overseas further study of subject leaders and young and middle-aged backbones has broadened the professional perspective of doctors, enhanced the innovative ability of young doctors, and improved the concept of international medical services.

scientific research

In the past five years, the Department of Hepatobiliary Oncology has undertaken 6 national key projects (major special projects, science and technology support plans, 973 projects), 3 National Clinical Medicine Center projects, 4 National Natural Science Foundation projects, and 7 provincial and municipal projects.

Doctors in the department have published more than 100 high-quality SCI papers and Chinese domestic core journal papers.

It has led and participated in more than 20 international and domestic multi-center clinical trials related to hepatobiliary tumors, actively improved diagnosis and treatment evidence, continued to improve diagnosis and treatment standards, continuously promoted the hospital's international reputation, and provided patients with valuable free treatment opportunities.